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Abstract
Objectives: This study aimed to assess the safety and feasibility of intraoperative device closure of
perimembranous ventricular septal defects (VSD) in young children guided by transthoracic echocardiography
(TTE).
Methods: We enrolled 18 patients from our hospital to participate in the study from June 2011 to September
2011. A minimal inferior median incision was performed after full evaluation of the perimembranous VSD by real-
time TTE, and a domestically made device was inserted to occlude the perimembranous VSD. The proper size of
the device was determined by means of transthoracic echocardiographic analysis.
Results: Implantation was ultimately successful in 16 patients using TTE guidance. In these cases, the complete
closure rate immediately following the operation and on subsequent follow-up was 100%. Symmetric devices were
used in 14 patients, and asymmetric devices were used in two patients. Two patient were transformed to surgical
treatment, one for significant residual shunting, and the other for unsuccessful wire penetration of the VSD. The
follow-up periods were less than nine months, and only one patient had mild aortic regurgitation. There were no
instances of residual shunt, noticeable aortic regurgitation, significant arrhythmia, thrombosis, or device failure.
Conclusions: Minimally invasive transthoracic device closure of perimembranous VSDs is safe and feasible, using a
domestically made device under transthoracic echocardiographic guidance, without the need for cardiopulmonary
bypass. This technique should be considered an acceptable alternative to surgery or device closure guided by
transesophageal echocardiography in selected young children. However, a long-term evaluation of outcomes is
necessary.
Keywords: CHD, septal defects, Cardiac intervention, Surgery
Introduction
Ventricular septal defect (VSD) is one of the most com-
mon congenital cardiac defects. The perimembranous
VSD accounts for 70% of autopsy findings in surgical
series, and is situated in thea r e aw e d g e db e t w e e nt h e
tricuspid and aortic valves. A significant proportion of
these defects require closure [1]. Transcatheter closure
and surgical repair are reliably achieved with no mortal-
ity and minimal morbidity [2-4]. As an alternative to
these closure methods, we employed an intraoperative
device and minimally invasive surgery to close perimem-
branous VSDs without cardiopulmonary bypass (CPB)
[5-7]. This minimally invasive treatment offers a good
cosmetic effect and is more acceptable to patients. We
have achieved high technical success and good acute
outcomes. Meanwhile, the procedure requires no
advanced or expensive equipment, and the cost is accep-
table in low-income nations. There are many reports on
the use of transesophageal echocardiography (TEE) for
transcatheter guidance or periventricular placement of a
VSD closure device [3,4,6]. To our knowledge, there are
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dance of intraoperative device closure of perimembra-
nous VSDs. TTE also provides an accurate and
noninvasive definition of the perimembranous VSD
anatomy using subcostal views, especially in young chil-
dren. Therefore, we used the subcostal window to pro-
vide an alternative to guide the intraoperative device
placement. This approach is easy to learn and manipu-
late. The aim of this study was to evaluate the safety
and feasibility of intraoperative device closure of the
perimembranous VSD in young children, under trans-
thoracic echocardiographic guidance.
Matreials and methods
This study was approved by the ethics committee of our
university and was conducted in accordance with the
tenets of the Declaration of Helsinki. Written informed
consent was obtained from the parents of the patients.
Devices
The entire delivery system consisted of a trocar, guide
wire, dilator and delivery sheath, and a loading sheath
made of polyethylene and acrylonitrile butadiene styrene
and disinfected with ethylene oxide. The device was
made by Lifetech Scientific (Shenzhen) Co, LTD of
China. The VSD occluder was a self-expandable, dou-
ble-disk device. There are two types of occluder, sym-
metric and asymmetric, that differ in their left
ventricular dish style. On the left ventricular side of
asymmetric device, the aortic end of the disk is 1 mm
wider than the waist, so as to avoid impinging the aortic
valve. The other side is 5 to 6 mm wider than the waist
and has a platinum marker to guide device orientation.
The symmetric device has a left ventricular disk that is
2 mm larger than the waist. The right ventricular disk is
2 mm larger than the waist in both types of occluders
( F i g u r e1 ) .T h es i z eo ft h eo c c l u d e r si sb a s e do nt h e
waist diameter, which ranged from 6 to 14 mm in 1-
mm increments. The occluders were implanted with a
6-9 F delivery sheath [6].
Patients
In the period between June 2011 and September 2011,
18 young children with perimembranous VSDs received
intraoperative, minimally invasive device closure in our
hospital. VSD was detected using TTE performed initi-
ally using standard transthoracic imaging with color and
Doppler interrogation from subxiphoid, apical, and para-
sternal views before the closure procedure. The patients
ranged in age from 2 to 36 months (mean ± standard
deviation, 12.0 ± 7.4 months) and weighed from 5 to 18
kg (mean = 10.2 ± 3.6 kg). For inclusion in the study,
(1) patients had to have perimembranous VSDs, (2) a
distance of over 2 mm rims of the VSD to nearby major
cardiac structures, such as the aortic, tricuspid, and pul-
monary valves, and (3) no aortic regurgitation. The pro-
cedure was used in patients weighing more than 5 kg,
o rh a v i n gV S Do fl e s st h a n1 0m mi nd i a m e t e r ,a n da
subaortic rim greater than 2 mm. Individuals with VSDs
of other sizes or locations or exhibiting coexisting car-
diac anomalies were excluded from our study. Other
inclusion criteria for intraoperative device closure were
the same as those used for surgical closure or transcath-
eter closure, which included hemodynamically signifi-
cant L-R shunts and/or significant chamber
enlargement, with or without mild-moderate pulmonary
hypertension despite medical therapy, and a history of
infective endocarditis. Patients were given routine exam-
inations, including a standard electrocardiogram, chest
X-ray, and blood tests. All patients had normal sinus
rhythm and normal left ventricular (LV) systolic func-
tion. Eight patients were symptomatic for respiratory
infection, palpitations, or exercise intolerance. Defect
diameters as measured by TTE ranged from 5 to 9 mm
(mean = 6.5 ± 1.0 mm). Six patients exhibited moderate
pulmonary hypertension (pulmonary arterial pressure >
40 mmHg).
Protocol
TTE was used to confirm the diagnosis of the isolated
perimembranous VSD in patients and to assess the cir-
cumferential margins for closure from subcostal, apical,
and parasternal views, especially from the edge to the
aortic valve. VSD diameter was measured by TTE before
the operation, using two-dimensional imaging and color
flow Doppler on long- and short-axis views. The choice
of occluder size was usually based on the largest size of
the defect on the TTE color Doppler image and was
basis on the maximum TTE-measured diameter plus 0-
Figure 1 The asymmetric device, the symmetric device, and
the entire delivery system.
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0 - 2m mi ne x c e s so ft h ew a i s td i a m e t e r ,w h i l et h es y m -
metric device is 2 mm in excess. When the defect was
aneurysmal or fenestrated, the maximum size of the
mouth of the aneurysm (true VSD) was recorded, as
well as the exit point of the main defect into the right
ventricle (RV).
General anesthesia was administered to patients, after
which they were placed in a supine position and draped
for exposure of the entire chest with a probe placed
below the xiphoid process to guide the whole procedure
(Figure 2). An inferior median sternotomy was per-
formed (about 3 cm). A small rib spreader was used in
this manipulation incision to facilitate instrumentation.
The pericardium was opened and suspended to expose
the right ventricle. On the free wall of the right ventri-
cle, two parallel 5/0 or 4/0 Prolene sutures of approxi-
mately 8 mm in diameter were stitched. Heparin (1 mg/
kg body weight) was administered intravenously, and
the activated clotting time was monitored to be greater
than 250 seconds. A modified short angiocatheter was
passed into the right ventricle through the free wall, and
the needle was removed. A floppy wire was advanced
through the angiocatheter and aimed toward the peri-
membranous VSD. The VSD was crossed, and the wire
was advanced through the defect into the left ventricle
(Figure 3). The dilator was removed, and an appropri-
ately sized delivery sheath was advanced over the wire
into the left ventricle. The wire and the dilator were
removed, and the sheath was allowed to back bleed to
ensure there was no entrapment of air (Figure 4). The
VSD occluder was immersed in saline, and screwed
onto the delivery cable. The device was loaded with the
help of a loading sheath. The loading sheath was intro-
duced into the delivery sheath, and the occluder was
advanced to the tip of the sheath. The sheath was pulled
back gently to leave the tip in the left ventricle. Under
TTE guidance, the left disc was deployed, and the
sheath was pulled back slowly until the left disc approxi-
mated the ventricular septum (Figure 5). To implant the
asymmetric device, it was rotated gently so that the pla-
tinum marker of the distal disk pointed downward and
the flat part of the disc was not directly under the aortic
valve (Figure 6). The waist and the right disc of the
occluding device were deployed while maintaining mod-
erate traction on the delivery cable (Figure 7). When
TTE evaluation showed there was no significantly resi-
dual shunt and no significant aortic or tricuspid valve
regurgitation, the occluder was released by rotating the
delivery cable counterclockwise. The sheath and the
d e l i v e r yc a b l ew e r ew i t h d r a w nw i t ht h es u t u r et i e d
snugly. Routine chest closure with placement of a drai-
nage tube were performed. Oral dipyridamole or aspirin
were prescribed to be taken for 3-6 months as an antic-
oagulant [5-7].
Statistical Analysis
Continuous data were presented as means ± standard
deviation and range.
Results
Occluder delivery was successful in 16 patients using
TTE guidance. The other two patients were transformed
to surgical closure, with significant residual shunting
resulting in occluder removal in one patient, and failure
to establish the occluder conveying rail in another
patient. In the 16 device-closure patients, the size of the
implanted occluder ranged from 6 to10 mm (8.1 ± 0.9
mm), and the diameter of the sheath was 6-9 F. Sym-
metric devices were used in 14 patients, and asymmetric
devices were used in two patients. The duration of the
procedure was 40 to 60 minutes (45 ± 5.5 minutes).
Patients were required to remain in the intensive care
u n i tf o r1 2t o2 4h o u r s( 1 5 . 5±1 . 4h o u r s ) ,a n dt o
remain in the hospital for 3 to 6 days (3.5 ± 1.3 days).
In those for whom occluder delivery was successful, the
overall immediate complete closure rate was 100%. All
patients were extubated within 12 hours and were dis-
charged within about 3 to 4 days after operation.
Minor complications were encountered in two
patient, including transient arrhythmia during device
implantation in one patient. Temporary sinus brady-
cardia was observed immediately in this patient, but a
normal rhythm recovered spontaneously. Mild aortic
regurgitation was found in one other patient, who was
followed up for 6 months without significant symp-
toms or aortic regurgitation deterioration. No episodes
of cardiac block, thromboembolism, or device displace-
ment were observed in the follow-up period of
hospitalization.
Figure 2 The image of the perimembranous VSD showed by
TTE subcostal views.
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in duration and were to be continued. Out-patient fol-
low-up was by functional, TTE, and ECG assessment. In
all symptomatic patients, symptoms were either resolved
totally or improved significantly. In those patients with
mild pulmonary hypertension, symptoms decreased
significantly as evaluated by tricuspid regurgitation jet.
The complete closure rate was 100% during the follow-
up. There were no episodes of hydrothorax, endocardi-
tis, thromboembolism, device disruption or failure, aor-
tic valves distortion, complete atrioventricular block, or
permanent rhythm disturbances. Chest incisions were
minor and cosmetic.
Figure 3 A floppy wire positioned from the right ventricle free wall into the left ventricle cavity across the VSD.
Figure 4 A sheath was advanced over the wire into the left
ventricle across the VSD. Figure 5 The left disc was deployed.
Cao et al. Journal of Cardiothoracic Surgery 2011, 6:166
http://www.cardiothoracicsurgery.org/content/6/1/166
Page 4 of 7Disscussion
Ventricular septal defect (VSD) is one of the most com-
mon congenital cardiac defects. Although it has been
established that both surgical and transcatheter closure
of VSDs are very safe, with negligible mortality rates
[2-4], these two methods still have some shortcomings.
They continue to be associated with large midline ster-
notomy and cardiopulmonary bypass, resulting in longer
hospital stays after closure surgery. Meanwhile, percuta-
neous approaches may cause potential vascular injury,
patients must be exposed to X-rays, and the techniques
involve expensive equipment and high costs. We used a
hybrid method as reported by Xing Quansheng and his
colleagues to close perimembranous VSDs [5], which
features intraoperative device closure and a minimally
invasive procedure. The use of TEE to guide transcath-
eter or periventricular device closure placement is well
known and has been associated with good results [3-5].
In our series, we used TTE to guide the intraoperative
device closure of the perimembranous VSD, which can
provided a useful subcostal window to finish the proce-
dure in the young children.
We limited the device closure to young patients
weighing more than 5 kg, with perimembranous VSDs
of less than 10 mm diameter with a sufficient subaortic
rim. The inferior median sternotomy offered an opera-
tive field and allowed the cardiac surgeons to do better
with traditional surgical techniques. The length of inci-
sion could be limited to 3 cm, and the procedure time
could be significantly shortened to 40 to 60 minutes,
owing to the avoidance of CPB. Moreover, our minimal
incision was easy to extend for conversion to a regular
open-heart procedure in the event of failure with intrao-
perative device closure, without the need for additional
incisions or rearranging the operation from the catheter-
ization laboratory to the operating room. This helped to
ensure the safety of the procedure. Consequently,
patients experienced less trauma, shorter operation
times and hospital stays, and faster recoveries than
those receiving surgical repair. Our method provides a
perpendicular angle to the perimembranous ventricular
septum, offering greater ease in guiding the wire
through the VSD and deploying the occluder into the
defect compared with transcatheter device closure. The
key point for the perimembranous VSD device closure
was the choice of the location for the placement of the
occluding device. Choosing patients with a sufficient
subaortic rim can guarantee the aortic valve will func-
tion from the influence of the occluder. It was impor-
tant to choose an occluder of the proper size as
measured by TTE, because one that is too large will
lead to aortic regurgitation, and one that is too small
will lead to residual shunting. In some patients, the sym-
metric device may interfere with the subaortic rim and
lead to aortic regurgitation, and in these instances an
asymmetric device can be applied. The special design of
t h ea s y m m e t r i cd e v i c ea l l o w e du st or o t a t ea n dm o v e
the sheath by hand to orient the platinum marker of the
distal left disk downward and position the flat part of
t h el e f td i s cs ot h a ti tw a sn o td i r e c t l yu n d e rt h ea o r t i c
valve. The 1-mm superior rim of the left ventricular
disk should avoid contact with the aortic valve, while
the larger 5-6 mm inferior rim with the platinum mar-
ker clasps the muscular septum. It was necessary to
observe the location of the occluder by TTE for about
10 to 20 minutes after release before the sheath and the
delivery cable were withdrawn. This allowed us to
retrieve the occluder and try again if the closure results
were not satisfactory.
In our study, device closure was successful in 16
patients. In two other patients that were referred for
surgical closure, we were not able to achieve a suitable
or stable occluder position, resulting in significant
Figure 6 Final image showed after an asymmetric device was
deployed.
Figure 7 Final image showed after a symmetric device was
deployed.
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ning the defect in the other case. According to our
experience, trivial or small residual shunts could be
ignored immediately after the release of device, since
they usually disappeared spontaneously during follow-up
period. After several weeks, endothelialization will occur
on the surface of the device, and neointima will form to
fully close any residual shunting [6]. In the other case,
the lack of success leaving a floppy wire across the
defect was due to the small size VSD. After a second
attempt we still couldn’t locate the VSD, and the proce-
dure was discontinued. During the surgical closure, we
found this perimembranous VSD was within about 3
mm of a ventricular septal aneurysm. Minor complica-
tions were encountered in two patients. Temporary
sinus bradycardia, which easily recovered spontaneously,
was observed in the course of device implantation in
one patient.
The only serious arrhythmic problem associated with
perimembranous VSD closure is the occurrence of com-
plete atrioventricular block (AVB), which can occur
days, weeks, or even months later. Sporadic studies have
reported the incidence of transient complete AVBs in
up to 1-5% of patients undergoing transcatheter device
closure of perimembranous VSDs [8-12]. Fortunately,
we did not encounter complete AVB in our study.
Compared with transcatheter closure of the perimem-
branous VSD, our approach provided a perpendicular
angle to the perimembranous ventricular septum. This
a l l o w st h es u r g e o nt oe a s i l yg u i d et h ew i r et h r o u g ht h e
VSD and deploy the occluder into the defect. The
chance of conduction system injury from mechanical
trauma/compression by the delivery system or device
seemed to be small in our series. Careful manipulation
of devices while crossing the defect is important and
can reduce the occurrence of arrhythmia. A suitable size
and position of the device must be verified carefully
using TTE, because using an oversized device or dislod-
gement of a too-small device may increase the risk of
arrhythmia. In our experience, the device selected
should be the same size or 1 to 2 mm larger than the
VSD, as measured by TTE. We recommend abandoning
the procedure if complete AVB develops.
Mild aortic regurgitation was found only in one
patient, who was followed up for six months without
significant symptoms or aortic regurgitation deteriora-
tion. The estimated incidence of aortic regurgitation fol-
lowing transcatheter closure ranges from 3.4 to 13.6%,
leading to complications that require urgent surgical
retrieval of the device [13]. Significant aortic regurgita-
tion following device occlusion may be due to impinge-
ment of the left ventricular disc on the leaflets of the
aortic valve. The specially designed superior rim of the
asymmetric device can maximum reduce the influence
of the aortic valve functions. We also suggest those
patients with aortic regurgitation during the device clo-
sure procedure should turn to surgical closure.
In those for whom the procedure was successful, the
closure rate were very impressive. Although there were
no episodes of cardiac block, thromboembolism, or
device displacement in the follow-up period, our follow-
ups were limited. More attention should be paid to the
routine follow-up.
It is well known that imaging of the perimembranous
VSD by TEE plays an essential role in the device closure
of ventricular septal defects. TEE is superior to any
other method for the measurement of rims and dimen-
sion of VSD [14,15]. Our study demonstrates that TTE
may be employed for definitive assessment of the peri-
membranous VSD, selection of patients for device clo-
sure, and guidance of intraoperative periventricular
device placement in young children. This is because
subcostal views provide relatively clear images of the
perimembranous VSD anatomy in young children. The
resolution and image quality of TTE is not as good as
TEE, but as we stated before, in a special subset of
patients the result of TTE-guidance to close the peri-
membranous VSD were the same as that with TEE-gui-
dance. This determines the accuracy of examination
results and affects the procedure of VSD closure gui-
dance. The deficiency of aortic rim is considered a risk
factor for unsuccessful closure and a significant predic-
tor for residual leakage [6], so we did not include
patients with aortic rim deficiencies or aortic regurgita-
tion in this study. Moreover, with careful manipulation,
TTE also provides an accurate distance from the edge of
the VSD to the aortic valve. Fortunately, the majority of
the perimembranous VSD patients in this study had suf-
ficient aortic rims, so the symmetric devices were mainly
applied in these circumstances. We would also empha-
size that TTE-guided perimembranous VSD closure was
only used with care by experienced surgeons and echo-
cardiographers. Concerning the use of TEE in infants,
there may still be a risk of complications such as gastro-
esophageal injury and respiratory compression [16]. We
might also still approve of using TEE to guide the VSD
device closure as the first choice, and do not advocate
the use of TTE to substitute completely for TEE. Our
initial study just shows that TTE by providing subcostal
views also offers a feasible means of guiding the VSD
device placement and could be as an alternative. With
increasing experience we hope that performing peri-
membranous VSD closure procedures under TTE gui-
dance can reduce procedure time and also provide
increased patient comfort, and that it may reduce the
need for TEE.
Like any retrospective study, there is bias associated
with data collection and the incomplete data for some
Cao et al. Journal of Cardiothoracic Surgery 2011, 6:166
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device closure cases, the conclusions were limited to our
own experience. Meanwhile, the average follow-up was
very short, and longer follow-up periods are needed in
future research. This study was limited to one institu-
tion, and other institutions may find different results. In
our study, the occluder was less expensive than the
Amplatzer occluder. The technique did not require an
expensive X-ray machine and was relatively easy to mas-
ter. This method should be the treatment of choice for
the effective treatment of perimembranous VSDs.
In conclusion, our study demonstrates that intraopera-
tive device closure of perimembranous VSDs using
TTE-guidance is safe and feasible. It has the advantages
of yielding cosmetic results and leaving less trauma than
surgical closure. Our initial study shows that TTE-gen-
erated subcostal views can also to be used to as an alter-
native to guide VSD device placement in young
children.
Authors’ contributions
HC collected the clinical data and performed the statistical analysis,
participated in the operation and drafted the manuscript. QC participated in
the operation and drafted the manuscript, revised and submitted the paper.
LC and HC designed the study and performed the operation. QL and ZQ
participated in the operation. GZ was the operator of echocardiography for
intraoperation TTE surveillance and provided the ultrasound images. All
authors read and approved the final manuscript.
Conflict of interests
The authors declare that they have no competing interests.
Received: 22 October 2011 Accepted: 28 December 2011
Published: 28 December 2011
References
1. Tynan M, Anderson RH: Ventricular septal defects. In Paediatric Cardiology..
2 edition. Edited by: Anderson RH, Baker EJ, Maccartney FJ, Rigby ML,
Shinebourne EA, Tynan M. London: Churchill Livingstone; 2002:983-1014.
2. Bol-Raap G, Weerheim J, Kappetein AP, Witsenburg M: Follow-up after
surgical closure of congenital ventricular septal defect. Eur J Cardiothorac
Surg 2003, 24:511-515.
3. Yang R, Sheng Y, Cao K, Kong X, Xu D, Yong Y, et al: Transcatheter closure
of perimembranous ventricular septal defect in children: safety and
efficiency with symmetric and asymmetric occluders. Catheter Cardiovasc
Interv 2011, 77:84-90.
4. Chessa M, Butera G, Negura D, Bussadori C, Giamberti A, Fesslova V, et al:
Transcatheter closure of congenital ventricular septal defects in adult:
mid-term results and complications. Int J Cardiol 2009, 133:70-3.
5. Quansheng X, Silin P, Zhongyun Z, Youbao R, Shengde L, Qian C,
Shuhua D, Kefeng H, Zhixian J, Qin W: Minimally invasive perventricular
device closure of an isolated perimembranous ventricular septal defect
with a newly designed delivery system: preliminary experience. J Thorac
Cardiovasc Surg 2009, 137:556-9.
6. Chen Q, Chen LW, Wang QM, Cao H, Zhang GC, Chen DZ: Intraoperative
device closure of doubly committed subarterial ventricular septal
defects: initial experience. Ann Thorac Surg 2010, 90:869-73.
7. Wang Q, Li Q, Zhang J, Wu Z, Zhou Q, Wang DJ: Ventricular septal defects
closure using a minimal right vertical infraaxillary thoracotomy: seven-
year experience in 274 patients. Ann Thorac Surg 2010, 89:552-5.
8. Walsh MA, Bialkowski J, Szkutnik M: Atrioventricular block after
transcatheter closure of perimembranous ventricular septal defects.
Heart 2006, 92:1295-7.
9. Butera G, Chessa M, Carminati M: Late complete atrioventricular block
after percutaneous closure of a perimembranous ventricular septal
defect. Catheter Cardiovasc Interv 2006, 67:938-41.
10. Yip WC, Zimmerman F, Hijazi ZM: Heart block and empirical therapy after
transcatheter closure of perimembranous ventricular septal defect.
Catheter Cardiovasc Interv 2005, 66:436-41.
11. Tao Zhou, Xiang-qian Shen, Sheng-hua Zhou: Atrioventricular Block: A
Serious Complication in and After Transcatheter Closure of
Perimembranous Ventricular Septal Defects. Clin Cardiol 2008,
31(8):368-371.
12. Dragos Predescu, Chaturvedi RRajiv, Friedberg KMark, Benson NLee,
Akira Ozawa, Kyong-Jin Lee: Complete heart block associated with device
closure of perimembranous ventricular septal defects. J Thorac
Cardiovasc Surg 2008, 136:1223-8.
13. Fu YC, Bass J, Amin Z, Fu YC: Transcatheter closure of perimembranous
ventricular septal defects using the new amplatzer membranous VSD
occluder: results of the US phase I trial. J Am Coll Cardiol 2006,
47:319-325.
14. Pedra CA, Pedra SR, Esteves CA, Pontes SC Jr, Braga SL, Arrieta SR:
Percutaneous closure of perimembranous ventricular septal defects with
the Amplatzer device: technical and morphological considerations.
Catheter Cardiovasc Interv 2004, 61:403-410.
15. Cao QL, Zabal C, Koenig P, Sandhu S, Hijazi ZM: Initial Clinical Experience
With Intracardiac Echocardiography in Guiding Transcatheter Closure of
Perimembranous Ventricular Septal Defects: Feasibility and Comparison
With Transesophageal Echocardiography. Catheterization and
Cardiovascular Interventions 2005, 66:258-267.
16. Greene MA, Alexander JA, Knauf DG, Talbert J, Langham M, Kays D,
Ledbetter D: Endoscopic evaluation of the esophagus in infants and
children immediately following intraoperative use of transesophageal
echocardiography. Chest 1999, 116:1247-50.
doi:10.1186/1749-8090-6-166
Cite this article as: Cao et al.: Intraoperative device closure of
perimembranous ventricular septal defects in the young children under
transthoracic echocardiographic guidance; initial experience. Journal of
Cardiothoracic Surgery 2011 6:166.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Cao et al. Journal of Cardiothoracic Surgery 2011, 6:166
http://www.cardiothoracicsurgery.org/content/6/1/166
Page 7 of 7